Spectrum, prevalence, and clinical correlates of PPM1D mutations in patients with clonal hematopoiesis and clonal cytopenias

作者：Talha Badar, Ludovica Marando, Eric Latorre-Crespo, Terra L. Lasho, Francyess Denis Oliva, Chenyu Lin, Benjamin J. McCormick, Mobachir El Kettani, Kashish Shah, Yael Kusne, Omer Jamy, Kendall Diebold, Alexander Coltoff, Christy M. Finke, James M. Foran, Mohamed A. Kharfan‐Dabaja, Yao‐Shan Fan, Liuyan Jiang, Rong He, M. Thomas, Anand Patel, D. Viswanatha, Maleeha Shah, Antoine N. Saliba, Abhishek A. Mangaonkar, Kristina Kirschner, Aref Al‐Kali, Naseema Gangat, Mark R. Litzow, Mrinal M. Patnaik · 发表于：Blood Advances · 年份：2026 · DOI：10.1182/bloodadvances.2025018031 · 被引用次数：4 · 研究领域：Acute Myeloid Leukemia Research、Cancer Genomics and Diagnostics、Cancer-related Molecular Pathways

ABSTRACT: TP53 and PPM1D are key regulators of DNA damage response and repair, and somatic mutations in these genes often co-occur in hematopoietic cells, expanding under genotoxic stress. Unlike TP53 mutations, where mechanisms of progression are defined, pathways underlying clonal fitness and transformation in PPM1D mutant cells remain unclear. In collaboration with 5 academic institutions, we analyzed the clinical and molecular landscape of 337 patients with clonal hematopoiesis (CH) and clonal cytopenia of undetermined significance (CCUS) across 4 genotypes: PPM1Dmt/TP53wt (n = 170 [50%]), PPM1Dmt/TP53mt (n = 25 [7%]), TP53mt/PPM1Dwt (n = 17 [5%]), and TP53wt/PPM1Dwt (n = 125 [38%]). All PPM1D variants were truncating, located in exon 6 of the gene, with a median variant allele frequency (VAF) of 6% (range, 0.3%-64%). The PPM1Dmt/TP53mt genotype was most frequently encountered in therapy-related CH/CCUS (t-CH/t-CCUS; 80%, 66.5%, 76.5%, and 19%; P ≤ .001) and had a shorter time interval to detection from last genotoxic exposure (6.2, 5.9, 11.25, and 24.5 months; P ≤ .001) compared with PPM1Dmt/TP53wt, TP53mt/PPM1Dwt, and TP53wt/PPM1Dwt genotypes, respectively. Acknowledging the short follow-up duration, rates of malignant transformation were lower in the PPM1Dmt/TP53wt (2%) and PPM1Dmt/TP53mt (4%) groups compared with PPM1Dwt/TP53wt (12%) and PPM1Dwt/TP53mt (17%) groups (P ≤ .001), respectively. In summary, PPM1D mutations are frequently observed in t-CH/t-CCUS, with low m...